NEW YORK, Jan. 30, 2018 /PRNewswire/ -- The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure.
The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The Cardiac assist devices (CAD) i.e. VAD, TAH and IABP are used to treat various conditions related to heart such as end stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis, etc.
The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body.
The indication for VAD use is acute cardiogenic shock (post cardiac surgery, myocarditis and massive myocardial infarction) and chronic heart failure. An artificial heart (TAH) is a mechanical assist device for persons with biventricular heart failure and heart transplant candidate which replaces both native ventricles and all four chambers of heart, thereby eliminating the symptoms of cardiac insufficiency or heart failure.
Intra-aortic balloon pump (IABP) is placed in aorta to help the heart to pump more blood by reducing the workload on the heart and improves the function of the left ventricle as this is the chamber that pumps blood into the aorta. IABP is used in conditions such as acute mitral valve regurgitation or severe heart failure, left ventricular failure, unstable angina, etc.
According to IQ4I Analysis, CAD market is expected to grow at double digit CAGR to reach $4,255.5 million by 2024. Products of Cardiac assist devices market is segmented into Ventricular Assist Device {(Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD)}, Total Artificial Heart (TAH) and Intra-Aortic Balloon Pump (IABP).
CAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. CAD market by implant type is segmented into Extracorporeal CAD, Intracorporeal CAD and Percutaneous CAD.
CAD market by patient type is segmented into Adult and Pediatric CAD. Applications of Cardiac assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR). End-User of Cardiac assist devices are segmented into hospitals, academics & research institutes and other End-user (catheterization labs and ambulatory settings).
